BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2005181)

  • 1. p53 mutations: gains or losses?
    Michalovitz D; Halevy O; Oren M
    J Cell Biochem; 1991 Jan; 45(1):22-9. PubMed ID: 2005181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53: an oncogenic transcription factor.
    Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
    Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor genes.
    Levine AJ
    Bioessays; 1990 Feb; 12(2):60-6. PubMed ID: 2140509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
    Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
    Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-function mutations in the tumor suppressor gene p53.
    van Oijen MG; Slootweg PJ
    Clin Cancer Res; 2000 Jun; 6(6):2138-45. PubMed ID: 10873062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 gene and its role in human brain tumors.
    Bögler O; Huang HJ; Kleihues P; Cavenee WK
    Glia; 1995 Nov; 15(3):308-27. PubMed ID: 8586466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activities of mutant p53: when mutations are more than a loss.
    Kim E; Deppert W
    J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53.
    Loging WT; Reisman D
    Oncogene; 1999 Dec; 18(52):7608-15. PubMed ID: 10602522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
    Willis A; Jung EJ; Wakefield T; Chen X
    Oncogene; 2004 Mar; 23(13):2330-8. PubMed ID: 14743206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
    Thomas S; Reisman D
    Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression in the lung of p53 mutant mice exposed to cigarette smoke.
    Izzotti A; Cartiglia C; Longobardi M; Bagnasco M; Merello A; You M; Lubet RA; De Flora S
    Cancer Res; 2004 Dec; 64(23):8566-72. PubMed ID: 15574763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators.
    Roemer K
    Biol Chem; 1999; 380(7-8):879-87. PubMed ID: 10494837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.